Cite
HARVARD Citation
Di Raimondo, C. et al. (2019). Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B‐cell lymphoma, leg type. British journal of haematology. pp. e79-e82. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Di Raimondo, C. et al. (2019). Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B‐cell lymphoma, leg type. British journal of haematology. pp. e79-e82. [Online].